Patterson Companies, Inc. Overview
Pro stress-test →Patterson Companies distributes and sells dental and animal health products across the United States, the United Kingdom, and Canada through Dental and Animal Health business units. The company transitioned to private ownership in April 2025 following acquisition by Patient Square Capital for approximately $4.1 billion announced in December 2024.
Strategic Profile
Pro stress-test →The Dental unit offers consumable products including infection control, restorative materials, hand instruments, dental equipment, and practice management software, while the Animal Health unit provides veterinary supplies, pharmaceuticals, vaccines, diagnostics, and practice management software. Under private equity ownership, Patterson prioritizes long-term growth and digital transformation for new technological offerings to dental and veterinary practices.
Competitive Landscape
Pro stress-test →Primary competitors in dental and healthcare distribution include Henry Schein, Cencora, and Cardinal Health, which occupy similar positions in specialty medical and dental supply distribution. Patterson differentiated through dual-market focus across dental and animal health, though competitive pressures in both segments have intensified in recent years.
Industry Context
Patterson Companies, Inc. operates in Healthcare supply and specialty distribution.
Key facts
Founded: 1877 · Headquarters: Saint Paul, US · Revenue: $6.51B (2024)